312 related articles for article (PubMed ID: 22682190)
41. Posaconazole as salvage therapy for zygomycosis.
Greenberg RN; Mullane K; van Burik JA; Raad I; Abzug MJ; Anstead G; Herbrecht R; Langston A; Marr KA; Schiller G; Schuster M; Wingard JR; Gonzalez CE; Revankar SG; Corcoran G; Kryscio RJ; Hare R
Antimicrob Agents Chemother; 2006 Jan; 50(1):126-33. PubMed ID: 16377677
[TBL] [Abstract][Full Text] [Related]
42. Invasive zygomycosis with a fatal outcome.
Abdel-Naser MB; Yousef N; el-Fakar NZ; Abdullatif OH; Wollina U; Abdallah MA
Arch Dermatol; 2005 Oct; 141(10):1211-3. PubMed ID: 16230557
[No Abstract] [Full Text] [Related]
43. Mucor circinelloides as a cause of invasive maxillofacial zygomycosis: an emerging dimorphic pathogen with reduced susceptibility to posaconazole.
Khan ZU; Ahmad S; Brazda A; Chandy R
J Clin Microbiol; 2009 Apr; 47(4):1244-8. PubMed ID: 19171681
[TBL] [Abstract][Full Text] [Related]
44. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
Lamaris GA; Ben-Ami R; Lewis RE; Chamilos G; Samonis G; Kontoyiannis DP
J Infect Dis; 2009 May; 199(9):1399-406. PubMed ID: 19358672
[TBL] [Abstract][Full Text] [Related]
45. Rhino-orbital zygomycosis secondary to Rhizopus oryzae in a renal transplant recipient successfully treated with liposomal amphotericin B.
Yassin MA; Taj-Aldeen SJ; Khan FY; Errayes M; Aref E
Chang Gung Med J; 2008; 31(4):407-11. PubMed ID: 18935800
[TBL] [Abstract][Full Text] [Related]
46. Outcomes of invasive zygomycosis infections in renal transplant recipients.
Forrest GN; Mankes K
Transpl Infect Dis; 2007 Jun; 9(2):161-4. PubMed ID: 17462005
[TBL] [Abstract][Full Text] [Related]
47. Activity of posaconazole in treatment of experimental disseminated zygomycosis.
Dannaoui E; Meis JF; Loebenberg D; Verweij PE
Antimicrob Agents Chemother; 2003 Nov; 47(11):3647-50. PubMed ID: 14576138
[TBL] [Abstract][Full Text] [Related]
48. Rhinocerebral zygomycosis with pulmonary aspergillosis in a non-HIV-infected patient: an unusual case report from India.
Malhotra S; Duggal S; Bhatia NK; Sharma N; Hans C
J Med Microbiol; 2009 Jan; 58(Pt 1):146-150. PubMed ID: 19074669
[TBL] [Abstract][Full Text] [Related]
49. [Mucormycosis: therapeutic news].
Pilmis B; Lanternier F; Lortholary O
Med Sci (Paris); 2013 Mar; 29 Spec No 1():25-30. PubMed ID: 23510522
[TBL] [Abstract][Full Text] [Related]
50. Disseminated zygomycosis with involvement of the central nervous system.
Skiada A; Vrana L; Polychronopoulou H; Prodromou P; Chantzis A; Tofas P; Daikos GL
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():46-9. PubMed ID: 19754757
[TBL] [Abstract][Full Text] [Related]
51. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
Chamilos G; Lewis RE; Kontoyiannis DP
Clin Infect Dis; 2008 Aug; 47(4):503-9. PubMed ID: 18611163
[TBL] [Abstract][Full Text] [Related]
52. Cutaneous zygomycosis in immunocompetent patients in Mexico.
Ayala-Gaytán JJ; Petersen-Morfín S; Guajardo-Lara CE; Barbosa-Quintana A; Morfín-Otero R; Rodriguez-Noriega E
Mycoses; 2010 Nov; 53(6):538-40. PubMed ID: 19735441
[TBL] [Abstract][Full Text] [Related]
53. Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature.
Page RL; Schwiesow J; Hilts A
Pharmacotherapy; 2007 Feb; 27(2):290-8. PubMed ID: 17253919
[TBL] [Abstract][Full Text] [Related]
54. Wound zygomycosis: two cases with unusual manifestations.
Karim M; Ahmed R; Chishty K
Int J Infect Dis; 2001; 5(2):107-11. PubMed ID: 11468107
[No Abstract] [Full Text] [Related]
55. Zygomycosis: an emerging fungal infection.
Brown J
Am J Health Syst Pharm; 2005 Dec; 62(24):2593-6. PubMed ID: 16333056
[TBL] [Abstract][Full Text] [Related]
56. Cutaneous mucormycosis.
Chang H; Wang PN; Huang Y
Infection; 2018 Dec; 46(6):901-902. PubMed ID: 30091018
[No Abstract] [Full Text] [Related]
57. Forty-one recent cases of invasive zygomycosis from a global clinical registry.
Rüping MJ; Heinz WJ; Kindo AJ; Rickerts V; Lass-Flörl C; Beisel C; Herbrecht R; Roth Y; Silling G; Ullmann AJ; Borchert K; Egerer G; Maertens J; Maschmeyer G; Simon A; Wattad M; Fischer G; Vehreschild JJ; Cornely OA
J Antimicrob Chemother; 2010 Feb; 65(2):296-302. PubMed ID: 20008047
[TBL] [Abstract][Full Text] [Related]
58. Fatal Cutaneous Zygomycosis caused by Saksaenea Vasiformis.
Patel V; Shah V
J Assoc Physicians India; 2021 Feb; 69(2):71-72. PubMed ID: 33527819
[TBL] [Abstract][Full Text] [Related]
59. Rhino-cerebral zygomycosis resistant to antimycotic treatment: a case report.
Vyzantiadis TA; Kioumi A; Papadakis E; Braimi M; Dermitzakis E; Tsitouridis I; Antoniadis A
Mycoses; 2009 Jan; 52(1):87-90. PubMed ID: 18498302
[TBL] [Abstract][Full Text] [Related]
60. Rhinocerebral zygomycosis in Pakistan: clinical spectrum, management, and outcome.
Ikram M; Iqbal M; Khan MA; Khan E; Shah M; Smego RA
J Pak Med Assoc; 2011 May; 61(5):477-80. PubMed ID: 22204184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
